{"transactions":[{"id":1972927,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":116004,"kind":"person","name":"Inman Todd","position":1,"cik":"0001858241","reported_name":"Inman Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-03T20:31:50.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":1542,"derivative":{"underlying":"Common Stock","underlying_shares":771},"source":{"system":"sec-edgar","filing":"0001628280-23-006252","document":"wf-form4_167787549364146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023006252/wf-form4_167787549364146.xml","form_type":"4"}},{"id":1972926,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":116004,"kind":"person","name":"Inman Todd","position":1,"cik":"0001858241","reported_name":"Inman Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-03-03T20:31:50.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":233,"price":18.11,"value":4219.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":538,"source":{"system":"sec-edgar","filing":"0001628280-23-006252","document":"wf-form4_167787549364146.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023006252/wf-form4_167787549364146.xml","form_type":"4"}},{"id":1972925,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":116004,"kind":"person","name":"Inman Todd","position":1,"cik":"0001858241","reported_name":"Inman Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-03-03T20:31:50.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":771,"source":{"system":"sec-edgar","filing":"0001628280-23-006252","document":"wf-form4_167787549364146.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023006252/wf-form4_167787549364146.xml","form_type":"4"}},{"id":2142145,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":116004,"kind":"person","name":"Inman Todd","position":1,"cik":"0001858241","reported_name":"Inman Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option","published_at":"2022-10-05T17:13:07.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":19527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":19527,"derivative":{"exercise_price":15.04,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":19527},"source":{"system":"sec-edgar","filing":"0001628280-22-026029","document":"wf-form4_166498997232881.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828022026029/wf-form4_166498997232881.xml","form_type":"4"}},{"id":2142144,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":116004,"kind":"person","name":"Inman Todd","position":1,"cik":"0001858241","reported_name":"Inman Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2022-10-05T17:13:07.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":9973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":9973,"derivative":{"underlying":"Common Stock","underlying_shares":9973},"source":{"system":"sec-edgar","filing":"0001628280-22-026029","document":"wf-form4_166498997232881.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828022026029/wf-form4_166498997232881.xml","form_type":"4"}},{"id":2353953,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":116004,"kind":"person","name":"Inman Todd","position":1,"cik":"0001858241","reported_name":"Inman Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-03T21:46:03.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":2313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":2313,"derivative":{"underlying":"Common Stock","underlying_shares":2313},"source":{"system":"sec-edgar","filing":"0001213900-22-010598","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022010598/ownership.xml","form_type":"4"}},{"id":2353952,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":116004,"kind":"person","name":"Inman Todd","position":1,"cik":"0001858241","reported_name":"Inman Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option","published_at":"2022-03-03T21:46:03.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":4690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":4690,"derivative":{"exercise_price":43.24,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":4690},"source":{"system":"sec-edgar","filing":"0001213900-22-010598","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022010598/ownership.xml","form_type":"4"}}]}